Balyasny Asset Management’s Teladoc Health TDOC Stock Holding History

Balyasny Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Hold	144,600	–	–	﹤0.01%	2098
2026 Q1	$788K	Hold	144,600	–	–	﹤0.01%	2178
2025 Q4	$1.01M	Hold	144,600	–	–	﹤0.01%	2192
2025 Q3	$1.12M	Sell	144,600 -5,400	-4%	-$42.1K	﹤0.01%	2068
2025 Q2	$1.31M	Buy	+150,000	New	+$1.09M	﹤0.01%	1938
2023 Q1	–	Sell	-59,500	Closed	-$1.41M	–	3143
2022 Q4	$1.41M	Buy	+59,500	New	+$1.6M	﹤0.01%	1551
2020 Q4	–	Sell	-40,000	Closed	-$8.77M	–	1690
2020 Q3	$8.77M	Buy	+40,000	New	+$8.47M	0.06%	425

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Balyasny Asset Management's TDOC Position: Q2 2026 in Review

Balyasny Asset Management reduced its Teladoc Health (TDOC) stake by 51% in Q2 2026, selling an estimated $295K and leaving 42,284 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Balyasny Asset Management first reported a position in TDOC in Q2 2018 and has held it in 23 quarters since. The position peaked at $43.2M in Q2 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Balyasny Asset Management held 42,284 shares of Teladoc Health worth $359K as of Q2 2026.
Balyasny Asset Management sold 44,354 Teladoc Health shares in Q2 2026, an estimated $295K.
Teladoc Health made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2656 holding.
Balyasny Asset Management first reported a position in Teladoc Health in Q2 2018 and has held it in 23 quarters since.
Balyasny Asset Management's Teladoc Health position peaked at $43.2M in Q2 2023.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.